Transcription is the first and most heavily regulated step of gene expression. It’s the process where a cell copies a specific segment of DNA into an RNA molecule, which then serves as the instruction set for building a protein or carrying out other cellular functions. Without transcription, a gene stays silent, no matter how important its instructions might be. In practical terms, controlling when and how much a gene is transcribed is the primary way your cells control which genes are “on” and which are “off.”
What Transcription Actually Does
Your DNA contains roughly 20,000 protein-coding genes, but any individual cell uses only a small fraction of them at a time. Recent single-cell studies show that an individual cell transcribes somewhere between 0.02% and 3.1% of its genome at any given moment, even though bulk measurements across millions of cells detect transcription from over 80% of the genome. This means gene expression is extremely selective: each cell picks and chooses which genes to copy into RNA based on its type, its current needs, and signals from the environment.
The copying process works like this. An enzyme called RNA polymerase binds to a specific stretch of DNA just upstream of a gene, known as the promoter region. Helper proteins called sigma factors (in bacteria) or general transcription factors (in human cells) guide the polymerase to the right spot. Once locked on, the polymerase pries open about 13 base pairs of the DNA double helix, creating a small “bubble,” and begins reading one strand of DNA while assembling a matching strand of RNA. In human cells, the polymerase moves at typical speeds of 1 to 4 kilobases per minute, though some measurements have clocked it above 50 kilobases per minute on certain genes.
Why Transcription Is the Main Control Point
Cells don’t express every gene equally, and transcription is where most of that selectivity happens. The key players are transcription factors: proteins that bind to specific DNA sequences near or within a gene and either help recruit RNA polymerase (activators) or block it (repressors). A single gene can have binding sites for dozens of different transcription factors, and the combination of factors present in a cell at any moment determines whether that gene gets transcribed and how quickly.
This is what makes a liver cell different from a neuron, even though both contain identical DNA. Liver cells have a particular set of active transcription factors that switch on liver-specific genes, while neurons have a different set that activates brain-specific genes. The genome is the same; the transcription pattern is what differs.
Epigenetic Marks Fine-Tune Transcription
Beyond transcription factors, cells use chemical tags on DNA and on the proteins that package it (histones) to influence whether a gene can be transcribed at all. DNA methylation, the addition of a small chemical group to certain DNA bases, generally silences transcription. It does this in two ways: sometimes methylation directly prevents transcription factors from binding to DNA, and other times specialized proteins recognize the methylation marks and recruit enzymes that tighten the DNA packaging, making the gene physically inaccessible to RNA polymerase.
The reverse pattern holds too. Regions of DNA that lack methylation tend to be wrapped around histones carrying acetyl groups, a modification that loosens the packaging and makes genes easier to transcribe. These epigenetic modifications are highly localized. Methylation within a gene’s own sequence has a strong silencing effect, but methylation in distant regions has minimal impact on that gene’s transcription. This tight spatial control allows cells to silence one gene while leaving its neighbors fully active.
What Happens After Transcription
In human cells, the initial RNA copy (called pre-mRNA) isn’t ready to use right away. It contains stretches of non-coding sequence called introns that must be cut out, leaving only the coding segments (exons) stitched together into mature mRNA. This splicing step adds another layer of control to gene expression, because cells can include or exclude particular exons to produce different versions of the same protein from a single gene. A transcript that includes exons 1 through 5 might encode a full-length protein, while one that skips exon 3 could produce a shorter version with different properties.
This alternative splicing is one reason the human body can produce far more distinct proteins than it has genes. Different tissues, developmental stages, or cellular conditions favor different splicing patterns, effectively multiplying the output of a single transcription event into several functional products.
Transcription Doesn’t Tell the Whole Story
It’s tempting to assume that if a gene is heavily transcribed, the cell will be flooded with the corresponding protein. In reality, the correlation between mRNA levels and protein levels is surprisingly weak. One of the earliest systematic comparisons, conducted in yeast, concluded that mRNA data alone was insufficient to predict protein abundance. More than 15 years of improved technology have confirmed this finding across many organisms.
The gap exists because protein levels depend on additional factors beyond transcription: how efficiently the mRNA is translated by ribosomes, how quickly the mRNA degrades, and how fast the resulting protein is broken down. So while transcription sets the initial supply of instructions, the final amount of functional protein in a cell reflects regulation at every step downstream. Transcription is necessary for gene expression, but it’s not the only thing that determines the outcome.
Bacteria Handle It Differently
In bacterial cells, transcription and the next step (translation, where ribosomes read the mRNA to build proteins) happen simultaneously. Because bacteria lack a nucleus, ribosomes latch onto the mRNA and start translating it while RNA polymerase is still transcribing the rest of the gene. The speed of the polymerase and the speed of the lead ribosome are coordinated so the ribosome trails closely behind. This coupling means that in bacteria, transcription almost immediately results in protein production, with little opportunity for the kind of post-transcriptional editing that eukaryotic cells rely on.
Human cells, by contrast, keep these processes in separate compartments. Transcription occurs in the nucleus, and the mRNA must be processed, spliced, and exported to the cytoplasm before ribosomes can translate it. This physical separation creates multiple checkpoints where gene expression can be adjusted or shut down entirely after transcription has already occurred.
When Transcription Goes Wrong
Because transcription is so central to gene expression, errors or disruptions in the process are linked to serious diseases, particularly cancer. Tumor cells often hijack normal transcription controls, overactivating genes that drive cell growth or silencing genes that would normally stop it. This is why many cancer therapies target the transcription machinery directly.
Some drugs block the enzymes that add or remove epigenetic marks. Azacytidine and decitabine, for example, inhibit DNA methylation, reactivating tumor-suppressor genes that cancer cells have silenced. Vorinostat and panobinostat block histone deacetylases, keeping the DNA packaging in a looser, more transcription-friendly state around genes that slow tumor growth. Other drugs go after RNA polymerase itself or the signaling proteins that tell it where and when to act. CDK inhibitors like palbociclib, ribociclib, and abemaciclib (approved for hormone receptor-positive breast cancer since 2015) work partly by disrupting the cellular machinery that coordinates transcription with cell division.
The fact that so many drug strategies revolve around transcription underscores its role as the gateway to gene expression. Control transcription, and you control what the cell becomes, how it behaves, and whether it survives.